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Detection of kidney injury  
in real time
Paragas et al., Nat Med advance online publication, 16 January 2011, 
doi:10.1038/nm.2290
Disease processes, like life, occur in time, but our medical under-
standing and practice are hindered by the delay between the 
occurrence of initial biological events and our ability to detect 
them. Organisms respond to injury by pathologically activating 
homeostatic mechanisms, so that when the disease is apparent its 
phenotype is frequently a composite that masks the initial injury. 
The resulting complexity is a general problem in medical practice, 
but because of the kidney’s central role in maintaining homeostatic 
balance, nephrologists are particularly aware of it. For example, it 
is readily appreciated that detection of positive or negative devia-
tions from normal balance (acid–base, sodium, and so on) at the 
time of initiation is not yet possible. This is one of the reasons 
why the field of ‘biomarkers’ has exploded with such ferocity, 
particularly in nephrology. The promise is that we will be able to 
detect acute kidney injury before the patient’s clinical evolution 
(measured in days) makes the diagnosis evident. Although many 
proteins have been proposed to act as markers of kidney dam-
age, in most cases, no clear and quantitative link to the injured 
kidney has been demonstrated. In contrast, neutrophil gelatinase-
associated lipocalin (Ngal), which was first reported in ischemic 
kidneys with the use of gene arrays and in patients with the use of 
immunoblots, was found to be upregulated in serum and urine in 
a variety of kidney injuries, much earlier than the accumulation 
of creatinine in serum. To clarify the source or sources of Ngal, its 
relationship to damage in vivo, and the mechanisms of its expres-
sion, Paragas et al. developed an Ngal reporter mouse by inserting 
a double-fusion reporter gene encoding luciferase-2 and mCherry 
(Luc2-mC) into the Ngal locus. They found that unilateral ischemic 
kidney injury induced Ngal-Luc2-mC activity specifically in the 
injured kidney, and that the kidney’s response could be detected 
in the Ngal reporter mouse in real time (Figure). Importantly, the 
bioluminescence signal correlated with the level of urinary Ngal. 
Interestingly and unexpectedly, the authors found that the source 
of urinary Ngal after injury was the cells of the distal nephron. They 
also found that Ngal-Luc2-mC was not induced by volume deple-
tion, indicating that the reporter mouse was able to distinguish 
between acute kidney injuries and ‘prerenal’ azotemia, a problem 
that has vexed nephrologists since the beginning of the field. This 
elegant study shows that the Ngal-Luc2-mC mouse represents a 
noninvasive tool to assay kidney stress in real time. It also raises 
the possibility that the distal nephron may be more sensitive to 
injury than henceforth believed and that it might function as an 
injury sensor.
Juan Oliver
Podocyte-secreted angiopoietin-
like-4 mediates proteinuria
Clement et al., Nat Med 2011; 17: 117–122; doi:10.1038/nm.2261
A variety of structural proteins in the glomerular capillary loop 
have recently been implicated in albuminuria, but the pathogen-
esis of most forms of nephrotic syndrome are unclear. To detect 
mechanisms of proteinuria, Clement et al. injected a fraction of 
nephrotoxic serum (NTS) that induces complement- and leuko-
cyte-independent glomerular injury by direct antibody binding. 
They found that among the differentially expressed glomerular 
genes, Angptl4 was highly upregulated in podocytes. Angptl4 
encodes angiopoietin-like-4 (Angptl4), a secreted glycoprotein 
that belongs to the family of angiopoietin-like proteins. Angptl4 
is a target of the nuclear receptors peroxisome proliferator-acti-
vated receptor-a (Ppar-a) and Ppar-g. In normal rat glomeruli, 
Angptl4 localized in a capillary loop pattern that merged with the 
podocyte protein CD2 adaptor protein (CD2AP) (Figure). The 
authors found that Angptl4 mRNA expression also increased after 
administration of a single dose of puromycin aminonucleoside 
(that is, in puromycin aminonucleoside nephrosis) and in passive 
Heymann’s nephritis but did not change in anti-Thy1.1 nephritis 
Bioluminescent radiation from Ngal-Luc2-mC mice subjected to left 
kidney ischemia–reperfusion (I/R) for 15 or 30 minutes. Time after injury 
is indicated at the top.
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Detection by confocal microscopy of Angptl4 in rat glomeruli and colocal ization 
with podocyte protein CD2AP. Post-abs., postabsorbed antibodies.
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or in collapsing focal and segmental glomerulosclerosis. To assess 
the consequences of Angptl4 upregulation, they first examined an 
Angptl4 transgenic mouse. They found that glomeruli appeared 
normal by light microscopy, but electron microscopy revealed 
50% effacement or broadening of foot processes and showed that 
the mice had mild proteinuria. Analysis of a podocyte-specific 
increased expression of Angptl4 in a transgenic rat model (NPHS2-
Angptl4) showed that these animals had marked albuminuria, loss 
of glomerular basement membrane charge, and foot process efface-
ment. Interestingly, Angptl4−/− mice injected with NTS had less 
proteinuria than did control mice. The authors also found that 
Angptl4 secreted from podocytes in some forms of nephrotic syn-
drome lacked normal sialylation, and when they fed the sialic acid 
precursor N-acetyl-d-mannosamine to NPHS2-Angptl4 transgenic 
rats, it increased the sialylation of Angptl4 and decreased albu-
minuria by more than 40%. These results suggest that podocyte-
secreted Angptl4 has a key role in nephrotic syndrome.
Juan Oliver
Cholesterol efflux capacity,  
high-density lipoprotein  
function, and atherosclerosis
Khera et al., N Engl J Med 2011; 364: 127–135
Clinical trials have well established that statin therapy prolongs 
life, causing a decline in low-density lipoprotein cholesterol and 
an increase in high-density lipoprotein (HDL) cholesterol. The 
extent to which the absolute level of HDL describes how well HDL 
functions in managing cholesterol has not been fully described. 
Using two cohorts, Khera et al. used a functional assay to quan-
tify how well HDL mediates cholesterol removal from lipid-laden 
macrophages. The first cohort included 203 healthy white subjects 
with subclinical atherosclerosis, and the second included 793 white 
subjects without acute coronary syndrome, recruited before cardiac 
catheterization with at least one stenosis of 50% or more in a major 
coronary vessel. Blood samples were incubated with radiolabeled 
lipid-laden macrophages. The ability of the blood sample (that is, 
HDL cholesterol) to facilitate the efflux of the radiolabeled cho-
lesterol was quantified. As expected, the authors found significant 
correlations between cholesterol efflux capacity and level of HDL 
cholesterol and apolipoprotein A-I. While no significant relation-
ship between HDL cholesterol and carotid intima–media thickness 
was noted, a significant inverse relationship between cholesterol 
efflux capacity and carotid intima–media thickness was observed 
in both univariate and fully adjusted analyses. Increasing quartiles 
of cholesterol efflux capacity were associated with a lower likelihood 
of coronary artery disease in models adjusted for multiple other 
cardiac risk factors, including HDL cholesterol and apolipoprotein 
A-I. In these adjusted models, the association between efflux capac-
ity and coronary artery disease was independent of and stronger 
than the association of HDL cholesterol with coronary disease. In 
a substudy, smaller groups of patients were exposed to pioglitazone, 
placebo, or statin for periods of between 6 and 16 weeks. Among 
patients treated with pravastatin, atorvastatin, and placebo, no 
difference in cholesterol efflux capacity was seen in the period fol-
lowing treatment. Among the 16 patients treated with pioglitazone, 
however, the mean increase in efflux capacity was 11.3%.
This assay provides fascinating insight into how HDL cholesterol 
may be best utilized as an intermediate marker. Whether this assay 
or the absolute value of HDL cholesterol best correlates with hard 
cardiovascular outcomes has yet to be determined. However, it is 
clear that with respect to the physical presence of atherosclerosis 
(that is, carotid intima–media thickness versus the presence of 
coronary artery disease), this functional assay has a better asso-
ciation than does absolute HDL level.
Lynda Szczech
Cytokines induce small intestine 
and liver injury after renal ischemia 
or nephrectomy
Park et al., Lab Invest 2011; 91: 63–84; doi:10.1038/labinvest.2010.151
Patients with acute kidney injury (AKI) frequently suffer from 
extrarenal complications, including hepatic-pulmonary dysfunc-
tion, intestinal barrier disruption, and systemic inflammation. Park 
et al. tried to determine the mechanisms of this syndrome, which 
leads to the eventual development of sepsis and multiorgan fail-
ure. Mice subjected to AKI (renal ischemia–reperfusion (IR) or 
nephrectomy) rapidly developed acute hepatic dysfunction and suf-
fered significantly worse hepatic IR injury. After AKI, rapid peripor-
tal hepatocyte necrosis, vacuolization, neutrophil infiltration, and 
proinflammatory mRNA upregulation were observed, suggesting 
an intestinal source of hepatic injury. Small intestine histology after 
AKI showed profound villous lacteal capillary endothelial apop-
tosis, disruption of vascular permeability, and epithelial necro-
sis. After ischemic or non-ischemic AKI, plasma tumor necrosis 
factor-a (TNF-a), interleukin-17A (IL-17A), and IL-6 increased 
significantly. The small intestine appears to be the source of IL-17A, 
as IL-17A levels were higher in the portal circulation and small 
intestine than in the systemic circulation and liver. Wild-type mice 
treated with neutralizing antibodies against TNF-a, IL-17A, or IL-6 
and mice deficient in TNF-a, IL-17A, IL-17A receptor, or IL-6 were 
protected against hepatic and small intestine injury due to ischemic 
or non-ischemic AKI. This study demonstrates that both ischemic 
renal injury and nephrectomy initiate IL-17A generation in the 
small intestine, resulting in small intestinal and liver inflammation, 
apoptosis, and necrosis. The crucial functions of TNF-a and IL-6 
in generating these injuries are shown. Evidence is provided that 
small intestine-derived IL-17A causes further cytokine generation 
to induce hepatic injury and systemic inflammation. It would be 
highly relevant to determine the specific cell type or types respon-
sible for intestinal IL-17A generation and to elucidate the initial 
stimulus for producing intestine injury after AKI.
This important study is a step forward in the dissection of very 
early cell biological effects of AKI and may open new research lines 
to design more effective therapeutic approaches to AKI, a disease 
still associated with high mortality.
Marc De Broe
